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and David T Felson1* for the Multicenter Osteoarthritis Study GroupAbstract
Background: To examine if different rates of total knee replacement (TKR) in two similar cohorts with symptomatic
knee osteoarthritis (OA) were associated with different functional impact of disease.
Methods: Subjects from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI), persons
with or at high risk of OA, had knee radiographs, completed Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) surveys and had TKRs confirmed at each visit. At each visit, subjects were defined as having
symptomatic OA (SxOA) if ≥ one knee had pain and radiographic OA or if they had a TKR. WOMAC function
scores at each visit were compared by analysis of covariance adjusting for age, sex, body mass index, race, site,
depression, comorbidity, painful leg joints and knees affected. Post-TKR function scores were imputed to estimate
scores that would have been present without TKR.
Results: Subjects with SxOA (n > 750 in MOST and in OAI) had a mean age 66 to 67 years; most were women
and were White. Subjects were followed 4–5 years. Among those with SxOA, more TKRs were done in MOST
(35%) than OAI (19%). Adjusted mean WOMAC function (0–68, 68 = worst) improved from 26.9 to 21.9 in MOST
and from 24.5 to 22.0 in OAI (difference between MOST and OAI in change in WOMAC function, p = .01). Estimates of
function without TKRs showed function would not have changed in MOST (23.2 at baseline to 22.4).
Conclusions: Functional status of subjects with knee OA in MOST improved more than in OAI, probably because of
higher rates of TKRs. The decline suggests that TKR diminishes the functional impact of OA in the community.
Keywords: Total knee replacement, Function, EpidemiologyBackground
Knee osteoarthritis (OA) is a painful and disabling dis-
order affecting approximately 6% of US adults [1]. Medical
and rehabilitative treatments are limited and increasingly,
persons affected by disease have sought total knee replace-
ment (TKR). Of persons undergoing TKR 70-90% have a
marked reduction in pain and improvement in reported
function within 12 months after the surgery [2], but a sub-
stantial minority do not experience improvement [3,4].
Rates of TKR have increased dramatically in the last
25 years, with the numbers rising over 8-fold since 1980
[5] in the U.S. There has also been a marked rise in the
rates of TKR in the U.K. This increase has continued to* Correspondence: dfelson@bu.edu
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unless otherwise stated.occur in the 21st century with rates rising even in the last
5 years [6-9].
In two cohorts constituted of persons with or at high
risk of symptomatic knee OA, we discovered that over
time, participants in one of the cohorts underwent many
more TKR’s than those in the other cohort. This differ-
ence created a natural experiment to determine whether
among large cohorts containing numerous persons with
symptomatic knee osteoarthritis, a higher rate of TKR in
one cohort would lead to a reduction in the functional
impact of osteoarthritis compared with the other group.
While numerous studies have shown that individuals
undergoing TKR on average experience an improvement
in function [2] even compared with those who have OA
but do not undergo TKR [10], we are unaware of any
studies which have addressed whether the number of
TKR’s in a group with OA are sufficient to affect the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Niu et al. BMC Musculoskeletal Disorders 2014, 15:145 Page 2 of 7
http://www.biomedcentral.com/1471-2474/15/145overall impact of disease on function limitation in all
those with disease. Even if those with TKR have better
function than those with knee OA without TKR, the dif-
ference is not necessarily a large one and may not be
sufficient to have an effect on the population of persons
with knee OA until a large percentage of persons with
knee OA get replacements. In two cohorts with very dif-
ferent rates of TKR, we tested the overall functional im-
pact of TKR on function.
Methods
Patients and methods
We focused on data from two community based cohort
studies, the Multicenter Osteoarthritis Study (MOST)
and the Osteoarthritis Initiative (OAI). Both studies en-
rolled persons either with or at high risk of symptomatic
knee OA with the goal of identifying risk factors for inci-
dent and progressive knee osteoarthritis. Both studies
followed subjects for several years. In both cohorts, a
large proportion of persons with knee OA obtained knee
replacements during the follow-up. Informed consent
was obtained from all participants.
MOST
MOST recruited persons with or at high risk of knee
osteoarthritis from the communities of Birmingham,
Alabama and Iowa City, Iowa. Subjects with bilateral TKR
at baseline were excluded. 3,026 subjects aged 50–79 at
baseline were studied at baseline, 30 and 60 months. At
each visit, subjects filled out the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
survey for knees, were asked about pain in other joints,
and completed questionnaires on depressive symptoms
(CES-D) and co-morbidities (Charlson co-morbidity score).
Weight and height were measured and PA and lateral
weight bearing radiographs obtained. Radiographs were
read by a pair of experienced readers, with disagreement
resolved by adjudication [11]. Self-reported TKR was con-
firmed by radiographs and/or medical records.
For the purposes of this investigation, persons with
symptomatic knee osteoarthritis were identified separ-
ately at each visit. A person was defined as having this
entity if they had one knee with knee pain on most days
reported at the clinic visit and radiographs showing
osteoarthritis (Kellgren & Lawrence grade 2 or greater)
or if the person had a TKR at the time of the visit. To be
consistent in defining symptomatic OA at all visits, we
applied this definition to the baseline examination also.
The symptomatic knee osteoarthritis status of a subject
might change in either direction from one visit to the
next. For example, a person could develop new symp-
tomatic knee osteoarthritis if their knee pain was newly
reported or their symptomatic knee OA could go away if
their knee pain present at the earlier visit, resolved bythe later visit (knee pain is often episodic). The protocol
for the MOST Study was approved by IRBs at Boston
University, the University of Iowa, the University of
Alabama, Birmingham and the University of California,
San Francisco.
Osteoarthritis Initiative (OAI)
In the OAI Study subjects with or at high risk of knee
osteoarthritis were recruited from four communities:
Columbus, Ohio; Providence, Rhode Island; Baltimore,
Maryland and Pittsburgh, Pennsylvania. Eligibility for
OAI was similar to that of MOST with a few exceptions:
in OAI, the risk factors permitting eligibility to the study
were broader and age extended to those as young as age
45. Assessments were similar to MOST except that they
were done yearly. Other differences included:
1. Lateral weight bearing radiographs were not
acquired in OAI.
2. Subjects reported WOMAC function for each knee.
In OAI, knee radiographs were read and adjudicated
by the same team as in MOST using the same protocol.
We also used the same definition for symptomatic knee
osteoarthritis. Racial/ethnic background was determined
by subject self-report.
The higher (worse) WOMAC function score of the
two knees was used as the WOMAC function of a sub-
ject [12].
Of those with knee surgeries, 13 in the combined OAI
and MOST studies had partial knee replacements and
for analysis purposes, we lumped these with TKRs. The
OAI protocol was approved by the IRBs of all participat-
ing institutions including the Universities of Maryland,
Pittsburgh, and California, San Francisco, the Ohio
State University and that of Memorial Hospital, Rhode
Island.
Defining the impact of knee osteoarthritis
To assess functional status related to knee OA, we used
the WOMAC function scale in which subjects are asked
how much difficulty they have doing each of 17 activities
because of their knee [13]. Higher WOMAC function
scores (0–68 scale) signify worse function. We also ex-
amined WOMAC pain scores (0–20 scale, higher scores
signify worse pain).
Statistical analyses
To create comparable subjects at each time point in
each study, we limited analyses of both cohorts to those
aged 55–79 years at each visit. We did this because knee
replacements are rare in persons under age 55. A person
under age 55 at baseline would enter into our group for
analysis purposes at the exam at which they reached age
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came greater than 79 years. For MOST, we looked at
three groups of subjects with symptomatic osteoarthritis:
one at baseline, another at 30 months and another at
60 months. For OAI, we used the same approach, only
applied it at each biannual visit through the 48 month
visit. At each time point, we examined which subjects
met criteria for symptomatic osteoarthritis and were in
the appropriate age window.
If removal of those with severe symptomatic knee OA
(because they got TKR’s) were to account for improve-
ment in functional status, we would anticipate that
those undergoing TKR would have substantially worse
function and pain scores prior to surgery than those
not undergoing this surgery. To examine this question,
we focused on MOST or OAI examinations just prior
to subjects’ first TKR. We compared their WOMAC
function and pain scores from those pre-KR visits to
others in these cohorts who had symptomatic knee
osteoarthritis.
We estimated the crude mean WOMAC function
score at each time point, then used an ANCOVA model
to test whether there was a significant difference in ad-
justed WOMAC scores over time after adjusting for fac-
tors known to affect function in those with OA or in
those after TKR [14-16], age, sex, BMI, race, clinical site,
CES-D score, co-morbidity, number of painful joints in
lower limbs other than knees, and number of knees with
symptomatic OA. GEE was used to adjust for correlation
between repeated measures within a subject.
To examine whether differences in functional status of
SxOA emerged over time in MOST vs. OAI, we carried
out the same ANCOVA analyses adding study (MOST
or OAI) as an indicator variable and in addition added a
Time X study interaction term which tested whether the
two cohorts differed in the extent of change in WOMAC
function score over the course of follow-up.
To estimate the functional status that would have been
present in each cohort if there were no TKR’s during
follow-up, we examined subjects with symptomatic
osteoarthritis at baseline and not lost to follow-up. For
those who obtained TKR’s during the follow-up, we im-
puted WOMAC function scores at these post TKR visits
based on the covariates age, sex and race as well as their
baseline BMI, knee pain score, function score and Kellgren
& Lawrence grade. We used Markov Chain Monte Carlo
methods (MCMC) method to created five multiple im-
puted datasets. The mean WOMAC function scores were
pooled across the imputed datasets along with adjusted
variance and taking the uncertainty introduced by the im-
putation into account. We then described the distribution
of WOMAC function scores at each time point, first using
actually observed scores and again using the imputed
scores of those with a TKR.We carried out a secondary analysis in which instead
of self-reported function as a measure of disease impact,
we examined WOMAC pain score.
Results
In each of the MOST and OAI cohorts there were over
750 persons with symptomatic knee osteoarthritis at
each examination. Groups were similar both across time
points and across cohorts (see Table 1) with respect to
being in their late 60’s on average, being mostly women
and having a mean BMI in the obese range. Many sub-
jects had painful joints outside of their knees. More sub-
jects in MOST got their knees replaced than did OAI
subjects. The cumulative frequency of at least one TKR
in MOST subjects with symptomatic knee OA was
35.0% over 5 years (vs. 9.3% frequency in the same group
at study baseline). In OAI, the cumulative frequency was
only 18.6% over 4 years (see Figure 1) and, of this group,
6.5% had TKR at baseline. Also the WOMAC function
among those with symptomatic knee osteoarthritis was
worse among subjects with symptomatic osteoarthritis
in MOST than in OAI (for example, at baseline the
crude WOMAC function score was 24.3 in MOST vs.
19.6 in OAI).
When we examined the pre-KR status of persons who
later underwent TKR’s, we found that their WOMAC
function and pain scores were worse than those with
symptomatic OA who did not undergo TKR’s (for func-
tion in MOST, crude score 28.4 vs. 22.9, p < .0001; in
OAI, 24.8 vs. 18.0, p < .0001; for pain in MOST, crude
score 8.6 vs. 6.9, p < .0001 and for pain in OAI, crude
score 7.8 vs. 5.6, p < .0001).
In MOST we found an improvement in the adjusted
WOMAC function score (p < .0001) over time in per-
sons with symptomatic osteoarthritis, a group which as
noted above includes persons with TKR (see Figure 1top).
To determine whether this was partially accounted for
by removal of those with the most severe disease leaving
only those with milder disease, we excluded those sub-
jects with TKR (see Figure 1top). We found a drop in
the WOMAC function score, suggesting that at least at
60 months, those with the most severe knee osteoarth-
ritis had TKRs.
The improvement in physical functional status among
those with symptomatic knee OA was not as marked in the
OAI cohort (see Figure 1bottom). Even so, the WOMAC
function score improved significantly (p < .0001) and there
was a decline in WOMAC score even when we excluded
those who had TKR.
When we analyzed the combined group, we found that
those in MOST had an adjusted decrease (improvement) in
WOMAC function score of 1.0 per year (95% CI −1.2, −0.8)
and it was 0.6 per year for OAI (95% CI −0.9, −0.4). These
changes were unadjusted for WOMAC function differences
Table 1 Characteristics of participants with symptomatic knee OA in each cohort at each time point













Age, mean (SD), year 66.1 (6.4) 66.6 (6.7) 67.3 (6.8) 66.1 (6.7) 66.3 (6.9) 66.9 (7.1)
N (%) of women 541 (65.7) 527 (64.4) 512 (66.9) 515 (58.5) 486 (61.3) 451 (59.2)
N (%) of race
Whites 679 (82.4) 672 (82.2) 631 (82.5) 633 (71.9) 627 (79.1) 604 (79.3)
Blacks 137 (16.6) 139 (17.0) 118 (15.4) 219 (24.9) 147 (18.5) 135 (17.7)
Others 8 (1.0) 7 (0.9) 16 (2.1) 28 (3.2) 19 (2.4) 23 (3.0)
BMI, mean (SD), kg/m2 32.6 (6.6) 32.5 (6.5) 32.9 (6.8) 29.9 (4.7) 30.1 (4.8) 30.4 (4.9)
CES-D, mean (SD) 8.7 (8.5) 8.0 (7.6) 7.8 (7.6) 7.1 (6.9) 6.9 (7.3) 7.5 (7.5)
Charlson comorbidity score, mean (SD) 0.7 (1.0) 0.8 (1.2) 0.9 (1.4) 0.5 (0. 9) 0.6 (1.0) 0.5 (1.0)
# of painful joints in lower limb other than knee, mean (SD) 2.0 (1.9) 1.4 (1.7) 1.9 (1.8) 1.0 (1.4) 0.9 (1.3) 0.9 (1.3)
N (%) with KR
Unilateral KR 77 (9.3) 139 (17.0) 167 (21.8) 57 (6.5) 88 (11.1) 123 (16.1)
Bilateral KR 0 (0) 29 (3.6) 101 (13.2) 0 (0) 4 (0.5) 19 (2.5)
N (%) with partial and total KR
Partial KR 3 (0.4) 9 (1.1) 10 (1.3) 0 (0.00) 0 (0.00) 2 (0.3)
Total KR 74 (9.0) 158 (19.3) 257 (23.6) 57 (6.5) 92 (11.6) 139 (18.2)
Partial KR and total KR 0 (0) 1 (0.1) 1 (0.1) 0 (0) 0 (0) 0 (0)
WOMAC function, mean (SD) 24.3 (11.7) 23.0 (12.5) 19.0 (12.2) 19.6 (12.6) 17.5 (12.4) 17.0 (11.9)
Maximal WOMAC knee pain scale, mean (SD) 7.3 (3.7) 6.8 (3.9) 5.6 (3. 9) 6 (3.9) 5.6 (3.8) 5.5 (3.7)
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WOMAC function scores of MOST and OAI were different
and if the changes over time in function between the studies
was different (see Table 2) after adjusting for differences in
function scores between MOST and OAI. MOST subjects
with SxOA had a higher WOMAC function score than OAI
subjects (p < .001) but after adjusting for this and other fac-
tors, WOMAC function scores improved more in MOST
than in OAI (p = .01 for interaction of time X study). When
we removed persons with TKR from both cohorts, we no
longer found differences in change scores in OAI vs.
MOST.
To evaluate the effect of TKR on the average WOMAC
function score in persons with symptomatic knee osteo-
arthritis, we imputed WOMAC physical function scores
for subjects at the time of their replacements so that we
could project a WOMAC function score if they had not
had replacements (see Figure 2). In MOST, the imputed
WOMAC physical function scores did not change signifi-
cantly over time, starting at 23.2 and ending at 22.4. In the
OAI, there was an improvement in WOMAC physical
function score in the imputed sample from 19.3 to 17.6.
Using WOMAC pain as an outcome, a similar trend
for improvement was seen in both the MOST study
(adjusted pain score fell from 8.2 to 6.6, p < .0001) and
in the OAI (adjusted pain score fell from 7.4 to 7.0,p = .004). In similar analyses to those examining WOMAC
function, we found differences in pain change between
MOST and OAI, changes that were not present when we
removed persons with TKR’s.
Discussion
Our findings from two large cohort studies that included
persons with and at risk of symptomatic osteoarthritis
showed that the average physical function score for
those with symptomatic osteoarthritis improved more in
the cohort with the higher rate of TKRs. Our results
suggest that the functional impact of osteoarthritis will
decline modestly when the proportion of persons with
knee osteoarthritis with knee replacements rises dramat-
ically. Starting at baseline, the new TKR rate differed by
14% of those with disease in MOST vs. OAI (26% vs.
12%) and the WOMAC function score fell by 2.5 points
more in MOST.
While the rates of TKR in the population have in-
creased markedly including in the 2000s [6], there are
no population data on the proportion of those poten-
tially eligible for replacement who have actually had the
surgery. The cohorts we studied are drawn from the
community (and not from clinics) but are not necessarily
representative of the populations from which they were
drawn. Even so, these data provide a valuable projection
Figure 1 Secular trend of mean WOMAC function score among
subjects with symptomatic knee OA#.
Table 2 Secular trend of WOMAC function score in two
studies with interaction between study and time




Visit, year −0.64 (−0.88, −0.39) <.0001
Study MOST 3.15 (2.14, 4.16) <.0001
Study OAI 1.0 (referent)
Visit* study MOST −0.39 (−0.70, −0.08) 0.01
Visit* study OAI 1.0 (referent)
SxOA subjects, excluding those with TKR
Visit, year −0.50 (−0.726 -0.23) 0.0008
Study MOST 3.24 (2.20, 4.29) <.0001
Study OAI 1.0 (referent)
Visit* study MOST −0.08 (−0.41, 0.25) 0.64
Visit* study OAI 1.0 (referent)
*Adjusted for age, sex, BMI, race, clinical site, CES-D, co-morbidity, number of
painful joints in lower limbs other than knees, and number of knees with
symptomatic OA.
Figure 2 WOMAC function score observed in those with
symptomatic OA and WOMAC function score imputed in those
with symptomatic OA if there were no TKR#.
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status of populations with knee OA.
Previous studies have shown that persons after knee
replacement have an average improvement in physical
function not experienced by age and gender matched
controls without disease [17] and that they experience
relative improvements in function compared to matched
persons with symptomatic OA [10]. These studies com-
pared those with TKR to those without it, and our study
extends these findings by studying the entire population
likely to be affected by increased rates of this procedure
and examining the procedure’s overall impact on this
population.
What else might account for our findings? First, in
both the OAI and MOST, there might have been regres-
sion to the mean with subjects entering the study at a
time when they were experiencing severe pain and func-
tional limitation with a natural subsequent improvement.
Regression to the mean may well account for the improve-
ment in function at the beginning of the study in those
without TKR but it probably does not explain our find-
ings. When we imputed the function scores of those who
underwent TKR we saw constancy, especially in MOST,
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plained by regression to the mean (see Figure 2). If there
were regression to the mean, imputed scores would have
shown improvement. Also, regression to the mean would
have led to improvements in both cohorts and yet the im-
provement was significantly greater in MOST, the cohort
with the higher rates of TKR. Another explanation for the
improvement might be improved medical or rehabilitative
therapy for knee osteoarthritis, but there has been no ef-
fective new treatment widely adopted by patients since the
beginning of these studies. Further, we found no change
over time in the proportion of subjects using analgesics or
NSAIDs for OA in either cohort (data not shown).
OAI subjects with symptomatic OA had slightly
milder OA at study onset probably because of study eli-
gibility differences. Potential subjects with no knee pain
or obesity and with only hand OA and with parents or
siblings with knee replacement were eligible for OAI but
not for MOST.
One might speculate that the high rates of knee re-
placement in MOST are due in part to the locations of
these cohorts, situated in small cities with prominent
academic medical centers where TKR may be more
available than in the larger, more diverse cities where
OAI was situated. Also, OAI had a modestly higher pro-
portion of African Americans who generally have lower
rates of TKR utilization. The differences in the rates of
TKR in MOST and OAI cohorts may be informative in
terms of the ultimate effects of this surgery. They suggest
as TKR rates rise further that the improvement in physical
function experienced by symptomatic knee osteoarthritis
patients will be greater (see Figure 1).
There are a number of limitations to our work. First,
other factors could have accounted for the differences in
these cohorts. In MOST, the average function scores
were worse than in OAI and regression to the mean
could have been more marked there. Our analysis of
change adjusted this overall difference and showed a sig-
nificant difference with MOST subjects improving more
than OAI subjects even after adjustment for differences
in baseline function (see Table 2). Another potential
limitation is loss to follow-up. In both studies over 85%
of subjects initially recruited were tracked with respect
to symptomatic knee osteoarthritis status and functional
impact. Most of those lost in MOST were contacted by
phone and the proportion with TKR was similar to those
followed and who completed a WOMAC survey (37%
vs. 42%). suggesting that our estimates of the proportion
with TKR in the entire cohort are accurate. The follow-
up times were different in the two cohorts and this
could have introduced differences in WOMAC change.
An additional limitation is that we do not know in either
of these studies how TKR’s were allocated and whether
they were carried out in those most likely to experiencefunctional improvement. Compared to rates and impact
in MOST, it is conceivable that lower rates of TKR
would lead to even larger improvements in function if
their allocation were optimal.
Our data suggest that TKR surgery has a broad effect
on the functional impact of knee osteoarthritis in the
community. This finding may be useful in assessing the
advantages and disadvantages of the large societal invest-
ment in TKR. The overall effects of TKR increase on the
larger population with knee OA were small–-one
WOMAC function point yearly was gained by the in-
crease in TKR rates in MOST compared with OAI. The
estimate of minimal clinically important impact for
WOMAC physical function after TKR is 14, and the
population effect seen is much smaller than this. While
considerable research has examined the extent of change
in functional status (e.g. as measured by the WOMAC)
that is clinically important for individuals, the extent of
change across populations that is meaningful and rele-
vant to policy decisions merits investigation. Even
though our findings suggest a favorable population effect
of TKR, they do not argue for more TKR’s without con-
sideration of clinical appropriateness.Conclusions
In summary, based on work from two large cohorts
drawn from communities in the United States in which
there has been a substantial difference in rates of TKR,
the group with the higher rate of TKR has had a greater
improvement in OA related functional status. The best
explanation for this is that the high rate of TKR’s has led
to a diminishing functional impact of disease.
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